105 related articles for article (PubMed ID: 3455636)
1. Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy.
Stewart AF; Burtis WJ; Wu T; Goumas D; Broadus AE
J Bone Miner Res; 1987 Dec; 2(6):587-93. PubMed ID: 3455636
[TBL] [Abstract][Full Text] [Related]
2. Two species of adenylate cyclase-stimulating activity in a murine squamous carcinoma model of humoral hypercalcemia of malignancy.
Burtis WJ; Broadus AE; Insogna KL; Weir EC; Stewart AF
Endocrinology; 1986 May; 118(5):1982-8. PubMed ID: 3009144
[TBL] [Abstract][Full Text] [Related]
3. Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancy.
Stewart AF; Insogna KL; Burtis WJ; Aminiafshar A; Wu T; Weir EC; Broadus AE
J Bone Miner Res; 1986 Jun; 1(3):267-76. PubMed ID: 2845726
[TBL] [Abstract][Full Text] [Related]
4. Synthetic and partially-purified adenylate cyclase-stimulating proteins from tumors associated with humoral hypercalcemia of malignancy inhibit phosphate transport in a PTH-responsive renal cell line.
Sartori L; Weir EC; Stewart AF; Broadus AE; Mangin M; Barrett PQ; Insogna KL
J Clin Endocrinol Metab; 1988 Feb; 66(2):459-61. PubMed ID: 3339117
[TBL] [Abstract][Full Text] [Related]
5. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Merryman JI; Rosol TJ; Brooks CL; Capen CC
Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
[TBL] [Abstract][Full Text] [Related]
6. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice.
Rosol TJ; Capen CC; Brooks CL
Cancer Res; 1987 Feb; 47(3):690-5. PubMed ID: 3467838
[TBL] [Abstract][Full Text] [Related]
7. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
Insogna KL
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
[TBL] [Abstract][Full Text] [Related]
8. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
Cisneros G; Lara LF; Crock R; Whittier FC
South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
[TBL] [Abstract][Full Text] [Related]
9. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.
Insogna KL; Weir EC; Wu TL; Stewart AF; Broadus AE; Burtis WJ; Centrella M
Endocrinology; 1987 May; 120(5):2183-5. PubMed ID: 3494596
[TBL] [Abstract][Full Text] [Related]
10. Skin-derived fibroblasts respond to human parathyroid hormone-like adenylate cyclase-stimulating proteins.
Wu TL; Insogna KL; Hough LM; Milstone L; Stewart AF
J Clin Endocrinol Metab; 1987 Jul; 65(1):105-9. PubMed ID: 3034948
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.
Burtis WJ; Wu T; Bunch C; Wysolmerski JJ; Insogna KL; Weir EC; Broadus AE; Stewart AF
J Biol Chem; 1987 May; 262(15):7151-6. PubMed ID: 3584110
[TBL] [Abstract][Full Text] [Related]
12. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.
Stewart AF; Insogna KL; Goltzman D; Broadus AE
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1454-8. PubMed ID: 6298791
[TBL] [Abstract][Full Text] [Related]
13. Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.
Stewart AF; Mangin M; Wu T; Goumas D; Insogna KL; Burtis WJ; Broadus AE
J Clin Invest; 1988 Feb; 81(2):596-600. PubMed ID: 3339131
[TBL] [Abstract][Full Text] [Related]
14. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
Linkhart TA; Mohan S; Jennings JC; Baylink DJ
Cancer Res; 1989 Jan; 49(2):271-8. PubMed ID: 2535957
[TBL] [Abstract][Full Text] [Related]
15. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains.
Stewart AF; Wu T; Goumas D; Burtis WJ; Broadus AE
Biochem Biophys Res Commun; 1987 Jul; 146(2):672-8. PubMed ID: 3619898
[TBL] [Abstract][Full Text] [Related]
16. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1 alpha, and granulocyte colony-stimulating factor.
Sato K; Fujii Y; Kakiuchi T; Kasono K; Imamura H; Kondo Y; Mano H; Okabe T; Asano S; Takaku F
Cancer Res; 1989 Sep; 49(17):4740-6. PubMed ID: 2474371
[TBL] [Abstract][Full Text] [Related]
18. [Malignancy-associated hypercalcemia].
Yamaguchi K
Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
[TBL] [Abstract][Full Text] [Related]
19. The relative potency of a human tumor-derived PTH-like adenylate cyclase-stimulating preparation in three bioassays.
Stewart AF; Wu T; Burtis WJ; Weir EC; Broadus AE; Insogna KL
J Bone Miner Res; 1987 Feb; 2(1):37-43. PubMed ID: 3455155
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
